T
First Tracks Biotherapeutics Inc
TRAX · NASDAQ · Healthcare · 1.5B
Closing price
$31.85
-0.50% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.8×
Enterprise value / EBITDAEV/EBITDA
-2.4×
Free cash flow yieldFCF yield
-21.7%
Return on equityROE
-57.8%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.